Targeting Hypoxia with Small-Molecule Anticancer Agents

Simple item page
dc.contributor.advisorPinney, Kevin G.
dc.contributor.authorLe, Evelyn
dc.contributor.departmentBiochemistry.en_US
dc.date.accessioned2016-08-10T16:09:29Z
dc.date.available2016-08-10T16:09:29Z
dc.date.copyright2016-05-04
dc.date.issued2016-08-10
dc.description.abstractA vascular network delivers nutrients and oxygen to solid tumors, therefore selectively targeting tumor vasculature with anticancer agents represents a potentially promising therapeutic strategy. Small-molecule anticancer compounds that interact at the colchicine-binding site on beta-tubulin and inhibit microtubule formation can function as cytotoxic agents. In addition, a sub-set of these inhibitors of tubulin polymerization selectively disrupt blood flow to tumors and are referred to as vascular disrupting agents (VDAs). Through their ability to inhibit tubulin polymerization, VDAs induce morphology changes in the endothelial cells lining tumor vasculature, leading to vessel damage and ultimately precluding blood flow to the tumor. A variety of solid tumor cancers contain pronounced regions of low oxygen (hypoxia). In order to selectively target tumor hypoxia, small-molecule tubulin-binding agents (both antiproliferative agents and VDAs) can be synthetically linked to bioreductive triggers such as monomethyl or dimethyl nitrothiophenes, forming bioreductively activatable prodrug conjugates (BAPCs) that are designed to selectively release the anticancer agent in regions of hypoxia. The natural product combretastatin A-1 (CA1) and a synthetic analogue, phenstatin, are potent inhibitors of tubulin polymerization (IC50 = 1.9 μM and 1.0 μM, respectively) and CA1 functions as a VDA. The focus of this study centers on the synthesis of CA1 BAPCs that incorporate a monomethyl trigger and a phenstatin BAPC bearing a dimethyl trigger.en_US
dc.identifier.urihttp://hdl.handle.net/2104/9731
dc.language.isoen_USen_US
dc.rightsBaylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission.en_US
dc.rights.accessrightsWorldwide accessen_US
dc.subjectOrganic Chemistry and Biochemistryen_US
dc.titleTargeting Hypoxia with Small-Molecule Anticancer Agentsen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
revised 8 pdf.pdf
Size:
574.86 KB
Format:
Adobe Portable Document Format
Description:
Final thesis
Download
No Thumbnail Available
Name:
HR college agreement.pdf
Size:
724.55 KB
Format:
Adobe Portable Document Format
Description:
Honor College Aggreement
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.87 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Theses - Honors College